19
Stuart Brown Communications Manager Presented at Business - Sharing Value? 20 th September 2011, Edinburgh A NIDOS event www.nidos.org.uk GALVmed September~ NIDOS

Business - Sharing Value? GALVmed Case Study

  • Upload
    nidos

  • View
    1.087

  • Download
    1

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Business - Sharing Value? GALVmed Case Study

Stuart Brown

Communications ManagerPresented at Business - Sharing Value? 20th September 2011, Edinburgh

A NIDOS event www.nidos.org.uk

GALVmed

September~ NIDOS

Page 2: Business - Sharing Value? GALVmed Case Study
Page 3: Business - Sharing Value? GALVmed Case Study

What is GALVmed?

• The Global Alliance for Livestock Veterinary Medicines

• A Private Public Partnership

• Funded internationally, taking research from wherever it is best in the world seeking, where practicable, to produce and deliver from within Africa and South Asia

• Short term achievable goals, small footprint, driven by sustainability

We are currently funded by the Bill and Melinda Gates Foundation, DFID and the European Union

Page 4: Business - Sharing Value? GALVmed Case Study

What is our focus?

• To make a sustainable difference in the access to animal health medicines by poor livestock keepers (in support of the MDGs)

• To develop, register and launch 4 to 6 vaccine, pharmaceutical or diagnostic products by 2015 ( minimum targets)

• To work with partner agencies in developing countries to ensure sustainable research, production and delivery of these new products to poor livestock keepers

Page 5: Business - Sharing Value? GALVmed Case Study

Challenges to availability of appropriate new products

Discovery Research Development Registration Production Commer-

cialisationSustained delivery

Technical challenges.

Lack of appropriate product profiles

Ill-designed proofs-of-concept

Lack of funding for development studies - high risk, high cost.

Poorly designed, poorly controlledfield trials.

Unclear and varied regulatory requirements.

Lack of QA/QC.

Multiple regulatory authorities.

Lack of market pull-through

Poor estimates of need or demand

Inappropriate pack-sizes

Lack of knowledge or education on proper use

Inconsistent supply

Counterfeit products.

Lack of patent protection.

Poor quality and efficacy.

Our role is to facilitate leadership to overcome these challenges through creating partnerships

No commercial interest

Expensive processes

No process development

Page 6: Business - Sharing Value? GALVmed Case Study

Some of our Alliance members and operational partners

• FAO, OIE, African Union IBAR European Commission, Government of India, State of Haryana

• Farm Africa, Africare, Vetaid, Land O Lakes,Mercy Corps, ILRI, BAIF

• DIFD, Bill and Melinda Gates Foundation , European Union

• Pfizer, Merial, Intervet, CEVA, Indian Immunological, NVI, CTTBD, OBP

• OVI,( RSA), CIRAD, (France) NVI(Ethiopia) Universities of Melbourne, Queensland, Makerere, Sokoine,(TZ) Basle, Edinburgh, Pretoria, TANUVAS ,

Page 7: Business - Sharing Value? GALVmed Case Study

The growing reach of an Alliance

Enabling Activities:• 14 African countries (East, Central, Western & Southern Africa)• India & Nepal

Product development partners:EuropeAsiaNorth & Latin AmericaAustralia

Page 8: Business - Sharing Value? GALVmed Case Study

A Voice Empowers the PoorTabitha Maunder, Women's Dairy

Goat Project, Mwingi, Kenya

“ Before I became a buck keeper, I would never even be acknowledged or invited to a public meeting. Now I am not just invited but even given the opportunity to speak. I have been lifted from the ground to somewhere.”

Page 9: Business - Sharing Value? GALVmed Case Study

Business focusObjective 1

Develop data driven decision making tools

for socio economic impact and

understanding of markets

Objective 1

Develop data driven decision making tools

for socio economic impact and

understanding of markets

Objective 2

Developing 4 vaccines for 6 animal health diseases critical to poverty reduction

Objective 2

Developing 4 vaccines for 6 animal health diseases critical to poverty reduction

Objective 3

Addressing Adoption Access Supply,

creating value chains, defining sustainability

Objective 3

Addressing Adoption Access Supply,

creating value chains, defining sustainability

Objective 4

Communicate + network at all levels to

gain buy in to paradigm change

Objective 4

Communicate + network at all levels to

gain buy in to paradigm change

Central Skills

Leadership, Focus

Strategy

PartnershipPortfolio Development

Resourcing Monitoring + Evaluation

Page 10: Business - Sharing Value? GALVmed Case Study

Animal Health Industry

Donors

Governments

Poor Farmers

Universities

GALVmed

Potential

Solutions

Identified Need

Innovation

Research Institutions

Pro Poor Impact through

sustainable Animal Health

Solutions

Page 11: Business - Sharing Value? GALVmed Case Study

How do we do business?

• Ethical positioning of a charity

• Operational drive and methodology of a company

• Support and networking of an International Private Public Partnership

• Market driven, establishing value chains

We opened our doors in November 2005

Page 12: Business - Sharing Value? GALVmed Case Study

What are our Priority diseases?• Cattle

– East Coast Fever– Contagious Bovine

Pleuropneumonia– Hemorrhagic septicaemia– Trypanosomiasis

• Sheep and goats– Peste des petits ruminants– Contagious caprine

pleuropneumonia– Sheep & goat pox

• Pigs– Porcine cysticercosis– African swine fever– Classical swine fever

• Poultry– Newcastle disease– Highly pathogenic Avian

Influenza

• Multi-species– Rift Valley fever

Page 13: Business - Sharing Value? GALVmed Case Study

Current ProgrammesVACNADA ProjectBMGF/DFID Project

Process focused on capacity building for at least 8 African labs, related to vaccines for:-CBPP-CCPP-PPR-ND

(Kenya, Ethiopia, Ghana, Mali, Senegal, DRC, Botswana, Cameroon)

1- Regulatory Process2- Rift Valley Fever3- East Coast Fever4- Porcine cysticercosis5- Newcastle disease6- Intellectual Property

7- Contagious bovine pleuropneumonia8- Contagious caprine pleuropneumonia9- Peste des petits ruminants

Trypanosomosis Programme

African animal trypanosomosis:

- Vaccine- Medication-Diagnostics-Clinical trials

Page 14: Business - Sharing Value? GALVmed Case Study

Current partnership: 128

Legal agreements:82

(+ 45 in preparation)

Page 15: Business - Sharing Value? GALVmed Case Study

Intellectual AssetsThe main purpose of GALVmed’s IAmanagement is to ensure that Global Access is achieved

Ensuring that our investments into projects and technologies dobenefit the poor farmers for whom livestock is a lifeline

The risk we face if we fail to do properly manage IA

– Lack of control of the fruits of our own investments, others reap the benefits

– In the long run we fail to achieve our objectives

– Weakening organizational strength

Page 16: Business - Sharing Value? GALVmed Case Study

Self-determination through livestock“I was so poor after my husband died that I was almost a beggar……. Today I am confident and earn money daily - I am a community animal health worker. I have 12 goats, several chickens and I’ve just bought a donkey to carry water.

My children are all at school and I am hoping my eldest boy will become a doctor. I don’t need a husband to support me now.”

Teresa Ndege- Kenyaa

Page 17: Business - Sharing Value? GALVmed Case Study
Page 18: Business - Sharing Value? GALVmed Case Study

Thank You!

Page 19: Business - Sharing Value? GALVmed Case Study

Presented at Business - Sharing Value? 20th September 2011, EdinburghA NIDOS event www.nidos.org.uk